Copyright
©The Author(s) 2024.
World J Clin Cases. May 26, 2024; 12(15): 2499-2505
Published online May 26, 2024. doi: 10.12998/wjcc.v12.i15.2499
Published online May 26, 2024. doi: 10.12998/wjcc.v12.i15.2499
Table 1 Characteristics of the participants
| Primary site | n | Median survival time (95%CI, month) |
| CUP | 31 | 8.6 (1-16) |
| Gastric cancer | 24 | 6.0 (5-7) |
| Colorectal cancer | 21 | 8.5 (6-11) |
| Sarcoma | 10 | 9.2 (0-24) |
| Pancreatic cancer | 9 | 9.3 (3-16) |
| NET | 7 | 4.0 (2-7) |
| Esophageal cancer | 6 | 2.9 (1-4) |
| Skin cancer | 4 | 34.7 (4-66) |
| Thymic cancer | 3 | 14.0 (14-14) |
| Hematologic malignancy | 3 | Not reached |
| Urological cancer | 3 | 8.1 (0-17) |
| Others | 6 | 6.4 (3-10) |
| Overall | 136 | 8.1 (6-10) |
- Citation: Matsuda K, Shimazu K, Shinozaki H, Fukuda K, Yoshida T, Taguchi D, Nomura K, Shibata H. Recent trends in bone metastasis treatments: A historical comparison using the new Katagiri score system. World J Clin Cases 2024; 12(15): 2499-2505
- URL: https://www.wjgnet.com/2307-8960/full/v12/i15/2499.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i15.2499